Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Double-blind, Placebo Controlled, National, Multicenter Trial

NCT07143773 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT07143773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07143773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Double-blind, Placebo Controlled, National, Multicenter Trial
Lead sponsor
Odense University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
September 1, 2025
Completion date
August 1, 2027
Enrollment
88 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation recipients, non-diabetic patients, placebo control design, randomized controlled trial, sodium-glucose transporter 2 inhibitors